EMBR Global delivers pharmaceutical-grade custom molecule synthesis and research compound supply to leading institutions and compounding pharmacies — with rigorous documentation at every step.
From initial synthesis to final characterization, EMBR provides end-to-end compound development services built for research and pharmaceutical-grade applications.
End-to-end synthesis of custom peptides, APIs, and research compounds to precise structural and purity specifications.
Core ServiceFull analytical characterization including HPLC purity analysis, mass spectrometry, and structural verification with documented COA.
Quality AssuranceSpecialized synthesis of investigational peptides for academic and institutional research, formulated to IRB and research-grade standards.
Research SupplyScalable batch synthesis from milligram research quantities to gram-scale production runs, with consistent purity and documentation across lots.
ManufacturingCompliant bulk API and compound supply purpose-built for 503A and 503B compounding facilities with full traceability and regulatory documentation.
Pharmacy PartnerTechnical support for compounding pharmacies and research teams navigating FDA 503A/503B compliance and compound categorization requirements.
AdvisoryWe operate at the intersection of pharmaceutical manufacturing and institutional research — purpose-built for two demanding, compliance-minded audiences.
Our compliance infrastructure is the foundation of every client relationship. Institutional buyers and regulated pharmacies require a partner they can trust unconditionally.
Every compound synthesized by EMBR Global is produced under traceable, documented processes with full analytical verification. We do not release product without confirmed purity data and complete batch records — because our clients' compliance depends on ours.
We work with a select number of institutional and pharmacy clients. If you require pharmaceutical-grade synthesis from a compliant, documented CDMO — we'd like to hear from you.